Immediate Impact
55 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Roopesh Krishnankutty being referenced
Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Roopesh Krishnankutty | 426 | 230 | 123 | 168 | 31 | 780 | |
| Xin Qiu | 484 | 229 | 146 | 198 | 35 | 971 | |
| Shiguo Zhu | 538 | 214 | 163 | 188 | 34 | 853 | |
| Jinmei Jin | 535 | 217 | 112 | 123 | 36 | 881 | |
| Shanshan Deng | 433 | 212 | 82 | 239 | 32 | 881 | |
| Hana Jin | 497 | 184 | 148 | 130 | 33 | 925 | |
| Seunghwan Lim | 594 | 226 | 120 | 151 | 21 | 856 | |
| Tiankui Qiao | 383 | 163 | 85 | 145 | 39 | 658 | |
| Seongwon Choi | 426 | 186 | 151 | 179 | 17 | 854 | |
| Jian Lv | 565 | 246 | 100 | 165 | 39 | 898 | |
| Alice Santi | 424 | 171 | 106 | 187 | 26 | 856 |
All Works
Login with ORCID to disown or claim papers
Loading papers...